14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $33.24 $45.00 Tuesday, 23rd Apr 2024 CRBP stock ended at $37.74. This is 0.106% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 6.44% from a day low at $37.66 to a day high of $40.08.
90 days $7.44 $49.87
52 weeks $3.03 $49.87

Historical Corbus Pharmaceuticals Holdings prices

Date Open High Low Close Volume
Oct 27, 2020 $0.99 $1.00 $0.94 $0.99 1 368 480
Oct 26, 2020 $1.02 $1.03 $0.95 $0.96 2 394 110
Oct 23, 2020 $1.03 $1.09 $0.99 $1.01 2 467 323
Oct 22, 2020 $0.95 $1.04 $0.93 $1.04 3 878 967
Oct 21, 2020 $1.00 $1.01 $0.93 $0.94 4 188 344
Oct 20, 2020 $1.01 $1.03 $0.92 $0.98 5 811 052
Oct 19, 2020 $1.10 $1.11 $1.02 $1.02 5 440 789
Oct 16, 2020 $1.10 $1.13 $1.08 $1.11 2 303 892
Oct 15, 2020 $1.11 $1.12 $1.07 $1.11 2 332 502
Oct 14, 2020 $1.13 $1.14 $1.10 $1.11 2 073 951
Oct 13, 2020 $1.13 $1.14 $1.10 $1.12 2 087 113
Oct 12, 2020 $1.22 $1.22 $1.10 $1.14 4 400 650
Oct 09, 2020 $1.25 $1.26 $1.19 $1.20 3 460 478
Oct 08, 2020 $1.18 $1.26 $1.16 $1.23 4 679 549
Oct 07, 2020 $1.21 $1.27 $1.16 $1.21 7 362 185
Oct 06, 2020 $1.11 $1.28 $1.04 $1.21 25 402 182
Oct 05, 2020 $1.77 $1.89 $1.76 $1.89 2 707 956
Oct 02, 2020 $1.78 $1.92 $1.72 $1.80 2 809 454
Oct 01, 2020 $1.81 $1.86 $1.71 $1.86 2 823 752
Sep 30, 2020 $1.99 $2.07 $1.77 $1.80 4 987 028
Sep 29, 2020 $1.67 $2.05 $1.66 $1.97 8 047 766
Sep 28, 2020 $1.66 $1.67 $1.52 $1.64 3 528 505
Sep 25, 2020 $1.57 $1.70 $1.53 $1.57 4 201 258
Sep 24, 2020 $1.45 $1.59 $1.39 $1.54 4 947 950
Sep 23, 2020 $1.65 $1.66 $1.47 $1.51 6 919 077
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT